Does RIVAROXABAN Cause Haemoptysis? 1,961 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 1,961 reports of Haemoptysis have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 1.5% of all adverse event reports for RIVAROXABAN.
1,961
Reports of Haemoptysis with RIVAROXABAN
1.5%
of all RIVAROXABAN reports
438
Deaths
1,502
Hospitalizations
How Dangerous Is Haemoptysis From RIVAROXABAN?
Of the 1,961 reports, 438 (22.3%) resulted in death, 1,502 (76.6%) required hospitalization, and 95 (4.8%) were considered life-threatening.
Is Haemoptysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 1,961 reports have been filed with the FAERS database.
What Other Side Effects Does RIVAROXABAN Cause?
Gastrointestinal haemorrhage (20,041)
Haemorrhage (6,571)
Epistaxis (5,629)
Rectal haemorrhage (4,501)
Off label use (4,463)
Haematuria (4,387)
Upper gastrointestinal haemorrhage (4,247)
Cerebrovascular accident (4,111)
Anaemia (3,907)
Acute kidney injury (3,735)
What Other Drugs Cause Haemoptysis?
ASPIRIN (1,255)
APIXABAN (846)
TREPROSTINIL (838)
ALBUTEROL (652)
CLOPIDOGREL BISULFATE (643)
PREDNISONE (618)
WARFARIN (555)
ADALIMUMAB (472)
TIOTROPIUM (462)
MEPOLIZUMAB (449)
Which RIVAROXABAN Alternatives Have Lower Haemoptysis Risk?
RIVAROXABAN vs RIVASTIGMINE
RIVAROXABAN vs RIVOTRIL
RIVAROXABAN vs RIZATRIPTAN
RIVAROXABAN vs ROACTEMRA
RIVAROXABAN vs ROCURONIUM